← FDA DRUG APPROVALS

FDA ANDA · ANDA065500

AZITHROMYCIN

Sponsor: HOSPIRA

APPLICATION
ANDA065500
TYPE
ANDA
ORIGINAL APPROVAL
2009-06-26
LATEST ACTION
2020-01-27
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

AZITHROMYCINPrescription
AZITHROMYCIN EQ 500MG BASE/VIAL · INJECTABLE · INJECTION

Approval history

2020-01-27Labeling · Supplement 7 · standardAP
2020-01-27Labeling · Supplement 13 · standardAP
2020-01-27Labeling · Supplement 8 · standardAP
2015-03-19Labeling · Supplement 5 · standardAP
2015-03-19Labeling · Supplement 3 · standardAP
2012-10-11Labeling · Supplement 2 · standardAP
2009-06-26OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →